{"id":205068,"name":"RIDGEBACK BIOTHERAPEUTICS","slug":"ridgeback-biotherapeutics","state":"FL","country":"United States of America","description":"Biotechnology company focused on orphan and infectious diseases.","totalSpending":390000,"filings":11,"yearlySpending":[{"year":2020,"income":120000},{"year":2021,"income":180000},{"year":2022,"income":90000}],"issues":[{"code":"HCR","display":"Health Issues"}],"firms":["EAST END GROUP, LLC"],"lobbyists":["MICHAEL WOODY","ANDREW HAWKINS","DAVID MOHLER","KELLY CHILDRESS LANGE"],"govEntities":["Health & Human Services, Dept of (HHS)","HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Legislative and regulatory issues related to the development of vaccines and therapeutics for orphan and infectious diseases.","Legislative and regulatory issues related to pandemic and emerging infectious disease preparedness and response.","Legislative and regulatory issues related to pandemic and emerging infectious disease preparedness and response.","Legislative and regulatory issues related to pandemic and emerging infectious disease preparedness and response.","Legislative and regulatory issues related to pandemic and emerging infectious disease preparedness and response."]}